{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T05:07:47Z","timestamp":1792559267418,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejmech.2021.113903","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T15:52:51Z","timestamp":1633967571000},"page":"113903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability"],"prefix":"10.1016","volume":"227","author":[{"given":"Shujing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0580-1897","authenticated-orcid":false,"given":"Alexej","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed A.","family":"Zalloum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianguang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1544-606X","authenticated-orcid":false,"given":"Megan E.","family":"Meuser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1393-4665","authenticated-orcid":false,"given":"Xujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8368-3876","authenticated-orcid":false,"given":"Yucen","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasulu","family":"Cherukupalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2985-8890","authenticated-orcid":false,"given":"Erik","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1254-4473","authenticated-orcid":false,"given":"Christophe","family":"Pannecouque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Cocklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113903_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bcp.2012.12.011","article-title":"Antivirals: past, present and future","volume":"85","author":"De Clercq","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113903_bib2","doi-asserted-by":"crossref","first-page":"666388","DOI":"10.3389\/fimmu.2021.666388","article-title":"Role of circulating T follicular helper cells and stem-like memory CD4(+) T cells in the pathogenesis of HIV-2 infection and disease progression","volume":"12","author":"Ponnan","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2021.113903_bib3","doi-asserted-by":"crossref","first-page":"7887","DOI":"10.1021\/jm9004253","article-title":"Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors","volume":"52","author":"Dang","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113903_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01299-18","article-title":"Vitro antiviral activity of cabotegravir against HIV-2","volume":"62","author":"Smith","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113903_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/COH.0b013e32835ef089","article-title":"Combined approaches for HIV cure","volume":"8","author":"Margolis","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.ejmech.2021.113903_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41577-018-0085-4","article-title":"Functional cure of HIV: the scale of the challenge","volume":"19","author":"Davenport","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2021.113903_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00775-18","article-title":"Design of novel HIV-1\/2 fusion inhibitors with high therapeutic efficacy in rhesus monkey models","volume":"92","author":"Chong","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2021.113903_bib8","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.amjcard.2015.03.025","article-title":"A\u00a0systematic review of the usefulness of statin therapy in HIV-infected patients","volume":"115","author":"Feinstein","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejmech.2021.113903_bib9","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1021\/acs.jmedchem.5b00497","article-title":"Anti-HIV drug discovery and development: current innovations and future trends","volume":"59","author":"Zhan","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113903_bib10","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.cclet.2020.03.028","article-title":"New techniques and strategies in drug discovery","volume":"31","author":"Du","year":"2020","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113903_bib11","doi-asserted-by":"crossref","first-page":"113380","DOI":"10.1016\/j.ejmech.2021.113380","article-title":"An insight on medicinal aspects of novel HIV-1 capsid protein inhibitors","volume":"217","author":"Sun","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113903_bib12","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00018-018-2772-5","article-title":"Cellular and molecular mechanisms of HIV-1 integration targeting","volume":"75","author":"Engelman","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2021.113903_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001220","article-title":"HIV capsid is a tractable target for small molecule therapeutic intervention","volume":"6","author":"Blair","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2021.113903_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/v13010125","article-title":"HIV capsid and integration targeting","volume":"13","author":"Engelman","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2021.113903_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cell.2007.08.018","article-title":"Structure of full-length HIV-1 CA: a model for the mature capsid lattice","volume":"131","author":"Ganser-Pornillos","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113903_bib16","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2009.04.063","article-title":"X-ray structures of the hexameric building block of the HIV capsid","volume":"137","author":"Pornillos","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113903_bib17","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.17063","article-title":"Crystal structure of an HIV assembly and maturation switch","volume":"5","author":"Wagner","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.ejmech.2021.113903_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.virusres.2014.07.010","article-title":"Roles of HIV-1 capsid in viral replication and immune evasion","volume":"193","author":"Le Sage","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.ejmech.2021.113903_bib19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrmicro3503","article-title":"HIV-1 capsid: the multifaceted key player in HIV-1 infection","volume":"13","author":"Campbell","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113903_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/life11020100","article-title":"Structure, function, and interactions of the HIV-1 capsid protein","volume":"11","author":"Rossi","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.ejmech.2021.113903_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12250-019-00095-3","article-title":"Multiple roles of HIV-1 capsid during the virus replication cycle","volume":"34","author":"Novikova","year":"2019","journal-title":"Virol. Sin."},{"key":"10.1016\/j.ejmech.2021.113903_bib22","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1021\/acs.biochem.6b00159","article-title":"HIV capsid assembly, mechanism, and structure","volume":"55","author":"Chen","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2021.113903_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00368-18","article-title":"Truncated CPSF6 forms higher-order complexes that bind and disrupt HIV-1 capsid","volume":"92","author":"Ning","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2021.113903_bib24","doi-asserted-by":"crossref","first-page":"6918","DOI":"10.1128\/JVI.00019-16","article-title":"Capsid-CPSF6 interaction is dispensable for HIV-1 replication in primary cells but is selected during virus passage in\u00a0vivo","volume":"90","author":"Saito","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2021.113903_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003693","article-title":"Nucleoporin NUP153 phenylalanine-glycine motifs engage a common binding pocket within the HIV-1 capsid protein to mediate lentiviral infectivity","volume":"9","author":"Matreyek","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2021.113903_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003969","article-title":"A\u00a0cyclophilin homology domain-independent role for Nup358 in HIV-1 infection","volume":"10","author":"Meehan","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2021.113903_bib27","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1038\/s41564-019-0592-5","article-title":"Cyclophilin A protects HIV-1 from restriction by human TRIM5\u03b1","volume":"4","author":"Kim","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113903_bib28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12977-014-0068-x","article-title":"MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1","volume":"11","author":"Fricke","year":"2014","journal-title":"Retrovirology"},{"key":"10.1016\/j.ejmech.2021.113903_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41564-021-00868-1","article-title":"Sec24C is an HIV-1 host dependency factor crucial for virus replication","volume":"6","author":"Rebensburg","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113903_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00135-20","article-title":"Remodeling of the core leads HIV-1 preintegration complex into the nucleus of human lymphocytes","volume":"94","author":"Blanco-Rodriguez","year":"2020","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2021.113903_bib31","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1073\/pnas.1920631117","article-title":"HIV-1 uncoats in the nucleus near sites of integration","volume":"117","author":"Burdick","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2021.113903_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature12769","article-title":"HIV-1 evades innate immune recognition through specific cofactor recruitment","volume":"503","author":"Rasaiyaah","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113903_bib33","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3390\/molecules25071687","article-title":"Recent advances in HIV-1 gag inhibitor design and development","volume":"25","author":"Dick","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113903_bib34","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2174\/1570162X14999160224103555","article-title":"HIV-1 capsid inhibitors as antiretroviral agents","volume":"14","author":"Thenin-Houssier","year":"2016","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.ejmech.2021.113903_bib35","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/COH.0000000000000472","article-title":"Inhibitors of the HIV-1 capsid, a target of opportunity","volume":"13","author":"Carnes","year":"2018","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.ejmech.2021.113903_bib36","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2174\/138955709787847958","article-title":"Capsid (CA) protein as a novel drug target: recent progress in the research of HIV-1 CA inhibitors","volume":"9","author":"Zhang","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113903_bib37","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1021\/ci500437r","article-title":"Structure-activity relationships of a novel capsid targeted inhibitor of HIV-1 replication","volume":"54","author":"Kortagere","year":"2014","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2021.113903_bib38","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1128\/JVI.05006-11","article-title":"Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid","volume":"86","author":"Kortagere","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2021.113903_bib39","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/JVI.01411-14","article-title":"Compensatory substitutions in the HIV-1 capsid reduce the fitness cost associated with resistance to a capsid-targeting small-molecule inhibitor","volume":"89","author":"Shi","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2021.113903_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02057-20","article-title":"Absence of lenacapavir (GS-6207) phenotypic resistance in HIV gag cleavage site mutants and in isolates with resistance to existing drug classes","volume":"65","author":"Margot","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113903_bib41","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3389\/fmicb.2019.01227","article-title":"GS-CA compounds: first-in-class HIV-1 capsid inhibitors covering multiple grounds","volume":"10","author":"Singh","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113903_bib42","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41586-020-2443-1","article-title":"Clinical targeting of HIV capsid protein with a long-acting small molecule","volume":"584","author":"Link","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113903_bib43","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/jac\/dkaa060","article-title":"Frequency of capsid substitutions associated with GS-6207 in\u00a0vitro resistance in HIV-1 from antiretroviral-naive and -experienced patients","volume":"75","author":"Marcelin","year":"2020","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2021.113903_bib44","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ejmech.2018.09.029","article-title":"Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound library","volume":"158","author":"Wu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113903_bib45","doi-asserted-by":"crossref","first-page":"112085","DOI":"10.1016\/j.ejmech.2020.112085","article-title":"Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities","volume":"190","author":"Sun","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113903_bib46","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1021\/acs.jmedchem.0c00015","article-title":"Design, synthesis, and mechanism study of benzenesulfonamide-containing phenylalanine derivatives as novel HIV-1 capsid inhibitors with improved antiviral activities","volume":"63","author":"Sun","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113903_bib47","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.4155\/fmc-2020-0084","article-title":"Medicinal chemistry strategies of targeting HIV-1 capsid protein for antiviral treatment","volume":"12","author":"Xu","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113903_bib48","first-page":"1070","article-title":"Exploring modifications of an HIV-1 capsid inhibitor: design, synthesis, and mechanism of action","volume":"5","author":"Xu","year":"2018","journal-title":"J.\u00a0Drug Des. Res."},{"key":"10.1016\/j.ejmech.2021.113903_bib49","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1021\/acs.jmedchem.0c01810","article-title":"Rapid optimization of the metabolic stability of a human immunodeficiency virus type-1 capsid inhibitor using a multistep computational workflow","volume":"64","author":"Meuser","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113903_bib50","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1128\/JVI.03116-15","article-title":"Roles of capsid-interacting host factors in multimodal inhibition of HIV-1 by PF74","volume":"90","author":"Saito","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2021.113903_bib51","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.apsb.2020.07.016","article-title":"Novel PF74-like small molecules targeting the HIV-1 capsid protein: balance of potency and metabolic stability","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2021.113903_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2021.113903_bib53","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bmcl.2015.12.087","article-title":"Identification of a small molecule HIV-1 inhibitor that targets the capsid hexamer","volume":"26","author":"Xu","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113903_bib54","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ab.2006.08.005","article-title":"Exploring \"one-shot\" kinetics and small molecule analysis using the ProteOn XPR36 array biosensor","volume":"358","author":"Bravman","year":"2006","journal-title":"Anal. Biochem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421007522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421007522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:31:24Z","timestamp":1759329084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421007522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":54,"alternative-id":["S0223523421007522"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113903","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113903"}}